TMEM16F scramblase regulates angiogenesis via endothelial intracellular signaling

Ke Zoe Shan1, Trieu Le1, Pengfei Liang1

  • 1Department of Biochemistry, Duke University, School of Medicine, Durham, NC 27710, USA.

PubMed

Insights

The protein TMEM16F ( anoctamin 6) regulates cell signaling and blood vessel formation. Its absence impairs angiogenesis by increasing Src kinase activity, offering new insights into lipid asymmetry in disease.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Physiology

Background:

  • TMEM16F (an octamin 6) is a Ca2+-activated lipid scramblase crucial for physiological and pathological processes.
  • Its precise regulatory mechanisms in these processes remain largely unknown.

Purpose of the Study:

  • To investigate the intracellular signaling function of TMEM16F in endothelial cell-mediated angiogenesis.
  • To elucidate the molecular mechanisms underlying TMEM16F's role in vascular development.

Main Methods:

  • Utilized a mouse model of developmental retinal angiogenesis.
  • Performed in vitro angiogenic assays.
  • Conducted biochemical analyses to assess Src kinase activity and VE-cadherin phosphorylation.

Main Results:

  • TMEM16F deficiency impaired developmental retinal angiogenesis in mice and disrupted in vitro angiogenic processes.
  • Absence of TMEM16F enhanced plasma membrane association of activated Src kinase.
  • This led to increased VE-cadherin phosphorylation and downregulation, suppressing angiogenesis.

Conclusions:

  • TMEM16F possesses a previously unrecognized intracellular signaling function in endothelial cells.
  • TMEM16F regulates angiogenesis through modulation of Src kinase and VE-cadherin.
  • Findings provide new avenues for understanding membrane lipid asymmetry and its role in disease pathogenesis.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.4K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.7K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K